NAVIDEA BIOPHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 376-400 of 949 matching filings.

Per page
25
Current page
16
SD File 001-35076

FORM SD

Filing date
31 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
08 May 2018
Reporting date
08 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
04 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
02 Apr 2018
Reporting date
28 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Mar 2018
Reporting date
15 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
14 Mar 2018
Reporting date
05 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
08 Mar 2018
Reporting date
05 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
23 Feb 2018
Reporting date
17 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Feb 2018
Reporting date
20 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Feb 2018
Reporting date
20 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Feb 2018
Reporting date
20 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Feb 2018
Reporting date
20 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-222092

EFFECT filing

Filing date
27 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
22 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-222092

FORM S-3

Filing date
15 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
08 Nov 2017
Reporting date
07 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35076

FORM 8-K

Filing date
13 Oct 2017
Reporting date
09 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Sep 2017
Reporting date
14 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .